Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma

Published:2020-10 Issue: Volume:491 Page:146-161
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Li Xue,Wei Yuquan,Wei Xiawei

Funder

Excellent Youth Foundation of Sichuan Scientific Committee Grant in China

National Major Scientific and Technological Special Project for “Significant New Drugs Development” of China

National Key Research and Development Program of China

National Natural Science Foundation Regional Innovation and Development

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference61 articles.

1. Cancer statistics;Siegel;CA A Cancer J. Clin.,2019

2. Epidemiology of lymphomas;Roman;Histopathology,2011

3. Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity;Sehn;Blood,2015

4. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray;Hans;Blood,2004

5. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab;Meyer;J. Clin. Oncol.,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single nucleotide polymorphism profiles of canine T-cell and null-cell lymphomas;Frontiers in Veterinary Science;2024-08-07

2. Stabilization of AMPK/PFKL/RPIA in the Glycolytic Bodies Transduces IL6/STAT3 Signal in Hepatocarcinogenesis;2024-03-04

3. STAT3 Expression and Its Correlation with PD‐L1 Expression in Non‐Hodgkin’s Lymphoma and Hodgkin’s Lymphoma at Dr. Saiful Anwar Regional Public Hospital in Malang, Indonesian Population;Advances in Hematology;2024-01

4. Caffeic acid phenethyl ester: Unveiling its potential as a potent apoptosis inducer for combating hypopharyngeal squamous cell carcinoma;Oncology Reports;2023-12-11

5. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action;Успехи химии;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3